Fig. 3From: Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosisComparison of Child–Pugh score and MELD score in the Rivaroxaban and Dabigatran groups. MELD score, Model for End-Stage Liver Disease score. AC, AnticoagulationBack to article page